Clinical trial • Phase III • Other
Clinical trial in Eosinophilic esophagitis
Phase III trial for Eosinophilic esophagitis. None/Not specified-controlled. 15 participants.
Overview
- Trial Therapeutic Area
- Other
- Trial Disease
- Eosinophilic esophagitis
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 23-01-2025
- First CTIS Authorization Date
- 28-01-2025
Trial design
None/Not specified-controlled Phase III trial in Spain.
- Comparator
- None/Not specified
- Target Sample Size
- 15
Recruitment
- Planned Sample Size
- 15
- Recruitment Window Months
- 55
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 15
Spain
- Earliest CTIS Part Ii Submission Date
- 21-01-2025
- Latest Decision Or Authorization Date
- 28-01-2025
- Processing Time Days
- 7
- Number Of Sites
- 1
- Number Of Participants
- 15
Sites
- Site Name
- Hospital General De Tomelloso
- Department Name
- Sección de Aparato Digestivo
- Principal Investigator Name
- Alfredo Lucendo
- Principal Investigator Email
- ajlucendo@sescam.jccm.es
- Contact Person Name
- Alfredo Lucendo
- Contact Person Email
- ajlucendo@sescam.jccm.es
- Number Of Participants
- 15
Sponsor
Primary sponsor
- Full Name
- Hospital General De Tomelloso
- Organisation Type
- Hospital/Clinic/Other health care facility
- Country Of Registered Address
- Spain
Related trials
Other published trials that may interest you.